Santarus to Webcast Analyst Day and Investor Briefing Presentation on January 19
SAN DIEGO, Jan. 19, 2011 /PRNewswire/ -- Santarus, Inc. (Nasdaq: SNTS) announces that a live audio webcast and accompanying slide presentation will be provided for its Analyst Day and Investor Briefing.
Details of the event are as follows:What:Santarus Analyst Day and Investor BriefingWhen:Today, Wednesday, January 19, 2011 at 4:15 p.m. Eastern timeWhere:www.santarus.com (under the Investor Relations link)AGENDAStrategic Overview and 2011 Financial Outlook
Gerald T. Proehl, President, Chief Executive Officer & Director, Santarus, Inc.CYCLOSET® - Clinical/Medical Background
Dr. J. Michael Gaziano, Chief, Division of Aging, Brigham & Women’s Hospital,
Professor of Medicine, Harvard Medical SchoolULTESA™ (Budesonide MMX®) – Overview and Top-line Phase III Clinical Study Results
Dr. Simon P.L. Travis, Consultant Gastroenterologist,
Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UKUlcerative Colitis – Treatment Perspective
Dr. William J. Sandborn, Professor of Clinical Medicine and Chief of the Division of Gastroenterology,
University of California, San DiegoRHUCIN® and Hereditary Angioedema (HAE)
Dr. Bruce L. Zuraw, Professor of Medicine and Chief, Allergy and Immunology, University of California, San Diego,
Research Scientist, San Diego VA HealthcareSAN-300 (anti-VLA-1 antibody)
Dr. Mark C. Totoritis, Senior Vice President, Biologics, Santarus, Inc.Wrap-up/Question & Answer Session
Gerald T. Proehl, President, Chief Executive Officer & Director, Santarus, Inc.
How:Live over the Internet – Simply log on t